$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997

(Khon Kaen, Thailand)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10% of complete FU at 5 years5-year absolute survival %5-year relative survival %
85-9293-9785-9293-97885-9293-97
C00Lip63.159.474.463.5
C01-02Tongue20.128.523.229.9
C03-06Oral cavity31.736.739.338.7
C11Nasopharynx26.831.829.132.9
C18Colon31.940.836.642.8
C19-20Rectum29.140.232.742.5
C32Larynx36.432.344.534.5
C50Breast44.960.847.162.2
C53Cervix54.553.357.554.5
C56Ovary34.058.635.659.4
C67Urinary bladder49.759.657.263.8
C81Hodgkin lymphoma29.468.331.169.5
C82-85+C96Non-Hodgkin lymphoma26.238.228.040.0


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Khon Kaen, Thailand, 1993-1997 cases followed-up until 2000)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Khon Kaen, Thailand, 1993-1997 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Khon Kaen, Thailand, 1993-1997 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Khon Kaen, Thailand, 1993-1997 cases followed-up until 2000)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Khon Kaen, Thailand, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997 (Khon Kaen, Thailand)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)